Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
93,227,509
-
Total 13F shares
-
90,531,530
-
Share change
-
-3,578,068
-
Total reported value
-
$480,772,771
-
Put/Call ratio
-
3.1%
-
Price per share
-
$5.31
-
Number of holders
-
217
-
Value change
-
-$73,903,605
-
Number of buys
-
129
-
Number of sells
-
104
Institutional Holders of MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN) as of Q2 2025
As of 30 Jun 2025,
MYRIAD GENETICS INC - Common Stock, par value $0.01 per share (MYGN) was held by
217 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
90,531,530 shares.
The largest 10 holders included
BlackRock, Inc., VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, STATE STREET CORP, GLENVIEW CAPITAL MANAGEMENT, LLC, MORGAN STANLEY, D. E. Shaw & Co., Inc., GEODE CAPITAL MANAGEMENT, LLC, DIMENSIONAL FUND ADVISORS LP, and Qube Research & Technologies Ltd.
This page lists
218
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.